Allergy Therapeutics plc

AIM:AGY Stock Report

Market Cap: UK£137.0m

Allergy Therapeutics Management

Management criteria checks 3/4

Allergy Therapeutics' CEO is Manuel Llobet, appointed in Jul 2009, has a tenure of 14.83 years. total yearly compensation is £411.98K, comprised of 83% salary and 17% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth £143.79K. The average tenure of the management team and the board of directors is 8.4 years and 2.6 years respectively.

Key information

Manuel Llobet

Chief executive officer

UK£412.0k

Total compensation

CEO salary percentage83.0%
CEO tenure14.8yrs
CEO ownership0.1%
Management average tenure8.4yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

Allergy Therapeutics plc (LON:AGY) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Dec 18
Allergy Therapeutics plc (LON:AGY) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Allergy Therapeutics plc's (LON:AGY) CEO Looks Like They Deserve Their Pay Packet

Nov 15
Allergy Therapeutics plc's (LON:AGY) CEO Looks Like They Deserve Their Pay Packet

Allergy Therapeutics (LON:AGY) Has A Pretty Healthy Balance Sheet

Sep 25
Allergy Therapeutics (LON:AGY) Has A Pretty Healthy Balance Sheet

CEO Compensation Analysis

How has Manuel Llobet's remuneration changed compared to Allergy Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-UK£50m

Sep 30 2023n/an/a

-UK£47m

Jun 30 2023UK£412kUK£342k

-UK£43m

Mar 31 2023n/an/a

-UK£36m

Dec 31 2022n/an/a

-UK£29m

Sep 30 2022n/an/a

-UK£21m

Jun 30 2022UK£665kUK£332k

-UK£14m

Mar 31 2022n/an/a

-UK£10m

Dec 31 2021n/an/a

-UK£5m

Sep 30 2021n/an/a

-UK£1m

Jun 30 2021UK£662kUK£324k

UK£3m

Mar 31 2021n/an/a

UK£5m

Dec 31 2020n/an/a

UK£7m

Sep 30 2020n/an/a

UK£7m

Jun 30 2020UK£614kUK£303k

UK£7m

Mar 31 2020n/an/a

UK£8m

Dec 31 2019n/an/a

UK£8m

Sep 30 2019n/an/a

UK£6m

Jun 30 2019UK£557kUK£295k

UK£3m

Mar 31 2019n/an/a

UK£117k

Dec 31 2018n/an/a

-UK£3m

Sep 30 2018n/an/a

-UK£5m

Jun 30 2018UK£556kUK£286k

-UK£8m

Mar 31 2018n/an/a

-UK£5m

Dec 31 2017n/an/a

-UK£3m

Sep 30 2017n/an/a

-UK£3m

Jun 30 2017UK£364kUK£273k

-UK£2m

Compensation vs Market: Manuel's total compensation ($USD516.97K) is below average for companies of similar size in the UK market ($USD772.87K).

Compensation vs Earnings: Manuel's compensation has been consistent with company performance over the past year.

CEO

Manuel Llobet (58 yo)

14.8yrs

Tenure

UK£411,982

Compensation

Mr. Manuel Llobet has been the Chief Executive Officer of Allergy Therapeutics plc since July 2009. Mr. Llobet joined Allergy in September 2009 following the successful refinancing by Azure Ventures Limite...

Leadership Team

NamePositionTenureCompensationOwnership
Manuel Llobet
CEO & Executive Director14.8yrsUK£411.98k0.10%
£ 143.8k
Shaun Furlong
CFO & Executive Directorless than a yearno datano data
Beverly Lees
Group Operations Director8.4yrsno datano data
Murray Skinner
Chief Scientific Officer8.4yrsno datano data
Santiago Puig
Business Development Director14.6yrsno datano data
Sue Baker
Head of Human Resourcesno datano datano data
Simon Piggott
Head of Clinical Science6.7yrsno datano data
Alan Bullimore
Head of Communication & Market Developmentno datano datano data
Russell Picket
Group Financial Controllerno datano datano data
Karley Charlotte Cheesman
Company Secretary1.3yrsno datano data
Matthew Heath
Principal Scientistno datano datano data

8.4yrs

Average Tenure

Experienced Management: AGY's management team is seasoned and experienced (8.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Manuel Llobet
CEO & Executive Director14.8yrsUK£411.98k0.10%
£ 143.8k
Shaun Furlong
CFO & Executive Directorless than a yearno datano data
Babatunde Otulana
Senior Independent Director6.9yrsUK£44.50k0.0010%
£ 1.4k
Peter Jensen
Independent Chairman13.6yrsUK£94.00k0.044%
£ 60.4k
Johannes Ring
Member of Scientific Advisory Boardno datano datano data
Hendrik Kees Nolte
Chairman of Scientific Advisory Boardno datano datano data
Anthony Frew
Member of Scientific Advisory Boardno datano datano data
Lawrence Du Buske
Member of Scientific Advisory Boardno datano datano data
Anthony Parker
Non-Executive Director1.4yrsno data0.040%
£ 55.3k
Cheryl Macdiarmid
Independent Non-Executive Director2.6yrsUK£40.00kno data
Zheqing Shen
Non-Executive Director1.4yrsno data0.0019%
£ 2.6k

2.6yrs

Average Tenure

58yo

Average Age

Experienced Board: AGY's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.